🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, single-center feasibility trial of patients with bord...
Status
Recruiting
Location
Juravinski Hospital
Start Date
2021-03-01
Trial ID
NCT04452461
Treatments Being Tested
This is a phase 1, first in human, dose escalation study for safety and fea...
Status
Recruiting
Location
Baylor College of Medicine Medical Center - McNair Campus
Start Date
2020-08-03
Trial ID
NCT04157127
Treatments Being Tested
The survival rate for patients with pancreatic cancer remains at a dismal 1...
Status
Recruiting
Location
University of Colorado
Start Date
2024-01-16
Trial ID
NCT06141031
Treatments Being Tested
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
The ACO/ARO/AIO-21 investigator-driven, open-labeled, phase I drug re-purpo...
Status
Completed
Location
University Hospital Goethe University Frankfurt
Start Date
2021-08-20
Trial ID
NCT04942626
Researchers want to learn if giving boserolimab (MK-5890) with standard tre...
Status
Withdrawn
Location
Optum Care Cancer Center ( Site 0004)
Start Date
2025-03-26
Trial ID
NCT06829199
The SHAPERS study is a multicentre, open-label, randomised, pragmatic clini...
Status
Recruiting
Location
ZAS Antwerpen
Start Date
2024-02-07
Trial ID
NCT06052332
This phase II is studying the side effects and how well carboplatin and pac...
Status
Completed
Location
Chao Family Comprehensive Cancer Center
Start Date
2008-02
Trial ID
NCT00618657
To assess the efficacy and feasibility of high-dose intensity-modulated rad...
Status
Unknown
Location
Shanghai Genernal Hospital
Start Date
2018-04-01
Trial ID
NCT03535207
Treatments Being Tested